Minerva Neurosciences Cash Flow - Quarterly (NASDAQ:NERV)

Add to My Stocks
$12.5 $0.2 (1.63%) NERV stock closing price Sep 25, 2018 (Closing)

The Minerva Neurosciences cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the Minerva Neurosciences debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Minerva Neurosciences revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Minerva Neurosciences cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Minerva Neurosciences had cash and cash equivalents of $82.98M at the beginning of the quarter and $68.78M at quarter end for 2018 Q2. Minerva Neurosciences has a positive cash and cash equivalents change of $42.65M.

View and download details of Minerva Neurosciences cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-24.94M-12.41M-31.52M-31.68M-20.42M-10.64M-31.04M-21.64M-13.21M-8M
Depreciation Depletion Amortization Cash-Flow-0.03M-0.02M--------
Net Increase (Decrease) in Assets Liabilities-1.18M-0.6M38.92M39.81M4.9M3.22M1.31M1.93M-0.79M1M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net4.01M2.11M-4.34M3.77M2.54M1.31M3.57M2.55M1.62M-
Net Cash from (used by) Operating Activities
-22.15M-10.93M3.09M12M-12.88M-6.04M-25.68M-16.76M-12.1M-6.04M
Increase (Decrease) in Prop Plant And Equipment---0.05M-------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments67.41M31.31M-107.13M-107.16M-27.36M-16.47M17.81M17.81M9.44M8.04M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
67.41M31.31M-107.18M-107.16M-27.36M-16.47M17.81M17.81M9.44M8.04M
Issuance (Purchase) of Equity Shares--55.04M55.04M9.93M9.63M81.96M80.73M80.72M18.54M
Issuance (Repayment) of Debt Securities-2.6M-1.28M-4.93M-3.67M-2.42M-1.2M-1.57M-0.38M--
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---2.94M-2.94M-0.04M--3.83M-3.83M-3.67M-
Net Cash from (used by) Financing Activities
-2.6M-1.28M47.16M48.43M7.46M8.43M76.56M76.51M77.04M18.54M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
42.65M19.09M-56.92M-46.72M-32.78M-14.08M68.69M77.56M74.38M20.53M
Cash & Equivalents at Beginning of Year82.98M14.28M18.54M1.81M------
Cash & Equivalents at Year End68.78M45.22M26.05M36.25M50.19M68.89M82.98M91.85M88.67M34.82M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Minerva Neurosciences stock comparison chart provides an easy way to compare the stock price with peers along with details of Minerva Neurosciences stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Minerva Neurosciences has cash of $68.78M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Minerva Neurosciences stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-22.15M for NERV.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $67.41M for NERV till last quarter 2018 Q2 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-2.6M for Minerva Neurosciences.

Key Financial Ratios For Minerva Neurosciences Cash Flow